申请人:Mycovia Pharmaceuticals, Inc.
                            
                            
                                公开号:US20190169159A1
                            
                            
                                公开(公告)日:2019-06-06
                            
                            The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.